These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 36232368)
1. Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia. Linh TTD; Hsieh YC; Huang LK; Hu CJ Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232368 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment. Nguyen DH; Cunningham JT; Sumien N Geroscience; 2021 Feb; 43(1):159-166. PubMed ID: 32902819 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of vascular cognitive impairment and dementia. Erkinjuntti T J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611 [TBL] [Abstract][Full Text] [Related]
8. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review. Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914 [TBL] [Abstract][Full Text] [Related]
9. The concept of vascular cognitive impairment. Erkinjuntti T; Gauthier S Front Neurol Neurosci; 2009; 24():79-85. PubMed ID: 19182465 [TBL] [Abstract][Full Text] [Related]
10. Language Impairment in Vascular Dementia: A Clinical Review. Macoir J J Geriatr Psychiatry Neurol; 2024 Mar; 37(2):87-95. PubMed ID: 37551643 [TBL] [Abstract][Full Text] [Related]
12. Clinical presentations and epidemiology of vascular dementia. Smith EE Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342 [TBL] [Abstract][Full Text] [Related]
13. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522 [TBL] [Abstract][Full Text] [Related]
14. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia. Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532 [TBL] [Abstract][Full Text] [Related]
16. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. Small G; Erkinjuntti T; Kurz A; Lilienfeld S CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529 [TBL] [Abstract][Full Text] [Related]
18. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Kalaria RN Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort. Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016 [TBL] [Abstract][Full Text] [Related]
20. [Mixed dementia: the role of cerebrovascular pathology]. Tabeeva GR Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):111-116. PubMed ID: 30335082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]